Psychosomatic Medicine Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published online before print July 18, 2007, 10.1097/PSY.0b013e31812f7b8e
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, P. J.
Right arrow Articles by Sherwood, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, P. J.
Right arrow Articles by Sherwood, A.
Psychosomatic Medicine 69:578-586 (2007)
© 2007 American Psychosomatic Society


ORIGINAL ARTICLES

Cerebrovascular Risk Factors, Vascular Disease, and Neuropsychological Outcomes in Adults With Major Depression

Patrick J. Smith, BA, James A. Blumenthal, PhD, Michael A. Babyak, PhD, Benson M. Hoffman, PhD, P. Murali Doraiswamy, MD, Robert Waugh, MD, Alan Hinderliter, MD and Andrew Sherwood, PhD

From the Department of Psychiatry and Behavioral Sciences (P.J.S., J.A.B., M.A.B., B.M.H., P.M.D., R.W., A.S.), Duke University, Durham, North Carolina; Department of Medicine (A.H.), University of North Carolina at Chapel Hill, North Carolina.

Address correspondence and reprint requests to Patrick Smith, Box 3119, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710. E-mail: Smith562{at}mc.duke.edu

Objective: To investigate the relationship of cerebrovascular risk factors (CVRFs), endothelial function, carotid artery intima medial thickness (IMT), and neuropsychological performance in a sample of 198 middle-aged and older individuals with major depressive disorder (MDD). Neuropsychological deficits are common among adults with MDD, particularly among those with CVRFs and potentially persons with subclinical vascular disease.

Methods: CVRFs were indexed by the Framingham Stroke Risk Profile (FSRP) and serum cholesterol levels obtained by medical history and physical examination. Patients completed a neuropsychological test battery including measures of executive functioning, working memory, and verbal recall. Vascular function was indexed by carotid artery IMT and brachial artery flow mediated dilation (FMD). Hierarchical multiple regression analyses were used to investigate the association between CVRFs, vascular disease, and neurocognitive performance.

Results: Greater FSRP scores were associated with poorer executive functioning (b = –0.86; p = .041) and working memory (b = –0.90; p = .024). Lower high-density lipoprotein levels also were associated with poorer executive functioning (b = 1.03; p = .035). Higher IMT (b = –0.83; p = .028) and lower FMD (b = 1.29; p = .032) were associated with poorer executive functioning after controlling for CVRFs. Lower FMD was also associated with poorer working memory (b = 1.58; p = .015).

Conclusions: Greater CVRFs were associated with poorer neuropsychological performance. Vascular dysfunction also was associated with neuropsychological decrements independent of traditional CVRFs.

Key Words: cerebrovascular risk • vascular disease • neuropsychological performance • depression • endothelial function

Abbreviations: CVRF = cerebrovascular risk factor; FSRP = Framingham Stroke Risk Profile; MDD = major depressive disorder; IMT = intima medial thickness; GTN = glyceryl trinitrate; GTN-D = glyceryl trinitrate dilation; FMD = flow mediated dilation; HDL = high-density lipoprotein; LDL = low-density lipoprotein; Ham-D = Hamilton Rating Scale for Depression; DSST = digit symbol substitution test; COWAT = controlled oral word association test; DST = digit span test; CHD = coronary heart disease.




This article has been cited by other articles:


Home page
Neurophysiology and Neurogenic Speech and Language DisordersHome page
L. L. Murray
Cognitive and Communicative Consequences of Cardiovascular Disease
Neurophysiology and Neurogenic Speech and Language Disorders, December 1, 2008; 18(4): 152 - 161.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Psychosomatic Society